MERLER, SARA
 Distribuzione geografica
Continente #
NA - Nord America 107
EU - Europa 66
AS - Asia 40
SA - Sud America 2
Totale 215
Nazione #
US - Stati Uniti d'America 107
CN - Cina 34
IT - Italia 13
SE - Svezia 13
GB - Regno Unito 12
IE - Irlanda 12
FR - Francia 8
DE - Germania 4
KR - Corea 3
BE - Belgio 2
FI - Finlandia 2
SG - Singapore 2
CL - Cile 1
EC - Ecuador 1
IN - India 1
Totale 215
Città #
Chandler 33
Dublin 12
Southend 12
Woodbridge 10
Ashburn 9
Verona 8
Beijing 6
New York 5
Tianjin 5
Ann Arbor 4
Jinan 4
Jacksonville 3
Lawrence 3
Princeton 3
Seoul 3
Brussels 2
Pieve Emanuele 2
Shenyang 2
Sindelfingen 2
Taiyuan 2
Wilmington 2
Zhengzhou 2
Changsha 1
Chicago 1
Fairfield 1
Frankfurt am Main 1
Guangzhou 1
Hebei 1
Helsinki 1
Lanzhou 1
Norwalk 1
Quito 1
Redmond 1
Sacramento 1
Seattle 1
Singapore 1
Taizhou 1
Washington 1
Totale 150
Nome #
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 81
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival 66
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin 35
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study) 31
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 11
Totale 224
Categoria #
all - tutte 893
article - articoli 893
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202013 1 1 0 0 1 1 1 1 2 0 0 5
2020/202123 2 4 1 3 0 3 0 7 0 0 3 0
2021/202234 2 7 2 5 1 1 0 2 2 1 3 8
2022/202386 3 8 8 13 9 22 0 5 11 0 4 3
2023/202446 1 4 4 7 4 10 6 1 0 4 5 0
Totale 224